StockData
P3 Health Partners Inc. logo

P3 Health Partners Inc. (PIIIW) stock

PIIIWNasdaqServices-Health ServicesFiscal year ends December 31Also trades as PIII
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 4/30
$0.01+0.00 (+14.89%)

Close on Oct 30, 2026Market cap $29.26MP/E –Yield –

P3 Health Partners ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

P3 Health Partners's ebitda for the twelve months ending Jun 30, 2026 was -$64.48M. For fiscal 2025 it was -$186.14M. The highest annual figure on record is -$27.79M in fiscal 2020.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$186.14M–
FY2024Dec 31, 2024-$234.60M–
FY2023Dec 31, 2023-$81.26M–
FY2022Dec 31, 2022-$1.47B–
FY2020Dec 31, 2020-$27.79M–
FY2019Dec 31, 2019-$39.14M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$62.27M–
Q1 FY2026Mar 31, 2026$29.31M–
Q4 FY2025Dec 31, 2025-$132.87M–
Q3 FY2025Sep 30, 2025-$23.19M–
Q2 FY2025Jun 30, 2025-$13.04M–
Q1 FY2025Mar 31, 2025-$17.04M–
Q4 FY2024Dec 31, 2024-$117.35M–
Q3 FY2024Sep 30, 2024-$85.32M–
Q2 FY2024Jun 30, 2024-$9.64M-1390.6%
Q1 FY2024Mar 31, 2024-$22.29M–
Q4 FY2023Dec 31, 2023-$42.63M–
Q3 FY2023Sep 30, 2023-$12.10M–
Q2 FY2023Jun 30, 2023$747.00K–
Q1 FY2023Mar 31, 2023-$27.28M–
Q4 FY2022Dec 31, 2022-$514.55M–
Q1 FY2022Jun 30, 2022-$920.88M–
Q3 FY2021Sep 30, 2021-$27.67M–
Q2 FY2021Jun 30, 2021-$25.54M–

More P3 Health Partners figures